statistiche ricercatore

Continente	#
NA - Nord America	538
AS - Asia	283
EU - Europa	272
SA - Sud America	55
Continente sconosciuto - Info sul continente non disponibili	38
AF - Africa	17
OC - Oceania	1
Totale	1.204

Nazione	#
US - Stati Uniti d'America	504
SG - Singapore	114
IT - Italia	70
CN - Cina	46
FI - Finlandia	45
BR - Brasile	43
RU - Federazione Russa	40
DE - Germania	38
HK - Hong Kong	32
SE - Svezia	22
VN - Vietnam	21
CA - Canada	19
GB - Regno Unito	16
TW - Taiwan	13
FR - Francia	10
IN - India	10
JP - Giappone	10
CI - Costa d'Avorio	8
NL - Olanda	8
ID - Indonesia	7
PL - Polonia	6
KR - Corea	5
CO - Colombia	4
DK - Danimarca	4
IQ - Iraq	4
TR - Turchia	4
ZA - Sudafrica	4
AR - Argentina	3
ES - Italia	3
MX - Messico	3
PK - Pakistan	3
SY - Repubblica araba siriana	3
AT - Austria	2
BD - Bangladesh	2
BE - Belgio	2
CR - Costa Rica	2
EC - Ecuador	2
EE - Estonia	2
KG - Kirghizistan	2
MA - Marocco	2
NI - Nicaragua	2
PR - Porto Rico	2
SA - Arabia Saudita	2
AE - Emirati Arabi Uniti	1
AU - Australia	1
CL - Cile	1
EG - Egitto	1
GR - Grecia	1
HT - Haiti	1
JM - Giamaica	1
KN - Saint Kitts e Nevis	1
LB - Libano	1
LC - Santa Lucia	1
ME - Montenegro	1
MR - Mauritania	1
PH - Filippine	1
PS - Palestinian Territory	1
SK - Slovacchia (Repubblica Slovacca)	1
SR - Suriname	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
UZ - Uzbekistan	1
VE - Venezuela	1
VG - Isole Vergini Britanniche	1
ZW - Zimbabwe	1
Totale	1.166

Nome	#
DEVELOPMENT OF PHENOXYALKYLPIPERIDINES AS HIGH-AFFINITY SIGMA-1 (s1) RECEPTOR LIGANDS WITH POTENT ANTI-AMNESIC ACTIVITY	205
Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration	196
Mrp1-collateral sensitizers as a novel therapeutic approach in resistant cancer therapy: An in vitro and in vivo study in lung resistant tumor	189
First-In-Class Thiosemicarbazone Metal Complexes Targeting the Sigma-2 Receptor (S2R) as an Innovative Strategy against Pancreatic Cancer	160
A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach	124
Sigma-2 Receptor Ligand Binding Modulates Association between TSPO and TMEM97	113
Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques	113
N‑Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R)	104
Totale	1.204

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	23	0	0	0	2	2	3	0	2	1	1	4	8
2022/2023	76	11	11	6	7	8	7	0	9	13	0	3	1
2023/2024	46	2	4	1	5	6	8	6	2	0	3	0	9
2024/2025	250	12	2	15	14	13	41	43	22	6	16	30	36
2025/2026	616	66	39	65	63	67	47	94	33	58	48	10	26
2026/2027	155	18	41	31	65	0	0	0	0	0	0	0	0
Totale													1.204